217 studies found for:    "Diabetic Nephropathies"
Show Display Options
Rank Status Study
1 Completed A Study in Patients With Diabetic Kidney Disease
Conditions: Diabetic Kidney Disease;   Diabetic Nephropathy;   Diabetic Glomerulosclerosis
Interventions: Drug: LY2382770;   Drug: Placebo
2 Recruiting Pyridorin in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetic Kidney Disease
Interventions: Drug: Pyridorin;   Drug: Placebo
3 Recruiting N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
Conditions: Diabetic Nephropathies;   Proteinuria;   Oxidative Stress
Interventions: Dietary Supplement: N-acetylcysteine;   Dietary Supplement: silibin;   Dietary Supplement: high-dose silibin;   Dietary Supplement: N-acetylcysteine placebo;   Dietary Supplement: silibin placebo
4 Recruiting Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
Conditions: Diabetes Mellitus, Type 2;   Diabetic Nephropathies
Interventions: Drug: Canagliflozin;   Drug: Placebo
5 Enrolling by invitation Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease
Conditions: Diabetic Nephropathies;   Hypertension
Interventions: Dietary Supplement: Standardized salt diet;   Drug: Amiloride
6 Active, not recruiting Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)
Condition: Diabetic Nephropathies
Interventions: Drug: BAY94-8862;   Drug: Placebo;   Drug: BAY 94-8862
7 Completed INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy
Condition: Diabetic Nephropathies
Interventions: Drug: Telmisartan capsule 40 mg;   Drug: Placebo;   Drug: Telmisartan capsule 80 mg
8 Completed Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease
Conditions: Diabetes Mellitus, Type I;   Diabetic Nephropathy
Intervention: Drug: Lisinopril
9 Active, not recruiting Minocycline and Proteinuria in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Minocycline 100 mg po bid for 6 months;   Drug: placebo
10 Recruiting Glutathione in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Proteinuria;   Oxidative Stress
Interventions: Drug: N-acetylcysteine placebo + silibin placebo;   Drug: N-acetylcysteine active + silibin placebo;   Drug: N-acetylcysteine placebo + silibin active;   Drug: N-acetylcysteine active + silibin active;   Drug: N-acetylcysteine active + high-dose silibin active
11 Completed Nitric Oxide (NO) Activity and Diabetic Nephropathy
Condition: Diabetic Nephropathies
Intervention: Drug: Folic Acid
12 Completed Spironolactone in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Spironolactone
13 Completed Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy
Conditions: Diabetic Nephropathies;   Diabetes Mellitus, Type II
Intervention: Drug: EDTA chelating agents
14 Completed Soy Protein in Early Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetes Mellitus
Intervention: Drug: soy protein
15 Completed Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: spironolactone
16 Unknown  Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease
Intervention: Drug: Mycophenolate Mofetil (MMF) ,phosphodiesterase 5 inhibitors , CARNITINE
17 Terminated Effect of Sulodexide in Overt Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Sulodexide
18 Completed Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease;   Diabetes Type 2
Intervention: Drug: N-acetylcysteine
19 Completed Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Sevelamer Carbonate;   Drug: Calcium Carbonate
20 Recruiting Renal Denervation in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Persistent Proteinuria With Type II Diabetes
Interventions: Procedure: Percutaneous renal denervation and TMNS;   Drug: Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years